#CRAVAT Report
#Created at Friday 05/03/2024 13:50:29
#Report level: variant
#
Variant Annotation																		Cancer Gene Census					Original Input			
UID	Chrom	Position	Ref Base	Alt Base	Variant Note	Coding	Gene	Transcript	Sequence Ontology	Exon Number	cDNA change	Protein Change	All Mappings	End Position	Sample Count	Samples	Tags	Driver class	Inheritance	Tumor types somatic	Tumor types germline	Link	Chrom	Pos	Reference allele	Alternate allele
1	chr1	22563636	A	T		Yes	EPHA8	ENST00000166244.8	start_lost	1	c.1A>T	p.Met1?	ENST00000166244.8:EPHA8:P29322:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000374644.8:EPHA8:P29322:missense_variant,start_lost:p.Met1?:c.1A>T	22563636	0		EPHA8						chr1	22563636	A	T
2	chr17	31095310	A	T		Yes	NF1	ENST00000358273.9	start_lost	1	c.1A>T	p.Met1?	ENST00000356175.7:NF1:P21359:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000358273.9:NF1:P21359:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000431387.8:NF1:P21359:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000487476.5:NF1:P21359:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000578268.1:MIR4733::2kb_upstream_variant,miRNA::; ENST00000583377.1:AC138207.2::lnc_RNA::	31095310	0		NF1	TSG, fusion	somatic/germline	neurofibroma, glioma	neurofibroma, glioma	NF1	chr17	31095310	A	T
3	chr7	55019278	A	T		Yes	EGFR	ENST00000275493.7	start_lost	1	c.1A>T	p.Met1?	ENST00000275493.7:EGFR:P00533:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000342916.7:EGFR:P00533:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000344576.6:EGFR:P00533:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000420316.6:EGFR:P00533:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000454757.6:EGFR::missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000455089.5:EGFR::missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000459688.1:EGFR::processed_transcript::; ENST00000463948.1:EGFR::processed_transcript::	55019278	0		EGFR	Oncogene	somatic/germline	glioma, NSCLC	NSCLC	EGFR	chr7	55019278	A	T
4	chr4	1793935	A	T		Yes	FGFR3	ENST00000340107.8	start_lost	2	c.1A>T	p.Met1?	ENST00000260795.7:FGFR3::missense_variant,start_lost,NMD_transcript_variant:p.Met1?:c.1A>T; ENST00000340107.8:FGFR3:P22607:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000352904.6:FGFR3:P22607:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000412135.6:FGFR3:P22607:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000440486.7:FGFR3:P22607:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000481110.6:FGFR3::missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000613647.4:FGFR3::missense_variant,start_lost:p.Met1?:c.1A>T	1793935	0		FGFR3	Oncogene, fusion	somatic	bladder, MM, T-cell lymphoma		FGFR3	chr4	1793935	A	T
5	chr10	87864470	A	T		Yes	PTEN	ENST00000371953.8	start_lost	1	c.1A>T	p.Met1?	ENST00000371953.8:PTEN:P60484:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000445946.4:KLLN:B2CW77:2kb_upstream_variant::c.-1983T>A; ENST00000487939.1:PTEN::processed_transcript::; ENST00000618586.1:PTEN::2kb_upstream_variant,processed_transcript::	87864470	0		PTEN	TSG	somatic/germline	glioma, prostate, endometrial	harmartoma, glioma, prostate, endometrial	PTEN	chr10	87864470	A	T
6	chr7	140924703	T	A		Yes	BRAF	ENST00000644969.1	start_lost	1	c.1A>T	p.Met1?	ENST00000288602.11:BRAF::missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000469930.2:BRAF::missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000496384.7:BRAF::missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000497784.2:BRAF::missense_variant,start_lost,NMD_transcript_variant:p.Met1?:c.1A>T; ENST00000642228.1:BRAF::missense_variant,start_lost,NMD_transcript_variant:p.Met1?:c.1A>T; ENST00000642808.1:BRAF::processed_transcript::; ENST00000643790.1:BRAF::processed_transcript::; ENST00000644969.1:BRAF::missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000646730.1:BRAF::missense_variant,start_lost,NMD_transcript_variant:p.Met1?:c.1A>T; ENST00000646891.1:BRAF:P15056:missense_variant,start_lost:p.Met1?:c.1A>T	140924703	0		BRAF	Oncogene, fusion	somatic	melanoma, colorectal, papillary thyroid, borderline ovarian, NSCLC, cholangiocarcinoma, pilocytic astrocytoma, Spitzoid tumour, pancreas acinar carcinoma, melanocytic nevus, prostate, gastric		BRAF	chr7	140924703	T	A
7	chr15	45378453	T	A		Yes	GATM	ENST00000396659.8	start_lost	1	c.1A>T	p.Met1?	ENST00000396659.8:GATM:P50440:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000458245.5:GATM::2kb_downstream_variant,processed_transcript::; ENST00000558118.1:GATM::missense_variant,start_lost,NMD_transcript_variant:p.Met1?:c.1A>T; ENST00000558336.5:GATM:P50440:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000560538.1:GATM::intron_variant,processed_transcript::; ENST00000617932.1:AC025580.3::2kb_upstream_variant,lnc_RNA::	45378453	0		GATM						chr15	45378453	T	A
8	chr17	7676594	T	A		Yes	TP53	ENST00000269305.8	start_lost	2	c.1A>T	p.Met1?	ENST00000269305.8:TP53:P04637:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000359597.8:TP53::missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000413465.6:TP53::missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000420246.6:TP53:P04637:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000445888.6:TP53:P04637:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000455263.6:TP53:P04637:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000504290.5:TP53:P04637:2kb_upstream_variant::c.-1379A>T; ENST00000504937.5:TP53:P04637:2kb_upstream_variant::c.-1379A>T; ENST00000510385.5:TP53:P04637:2kb_upstream_variant::c.-1379A>T; ENST00000574684.1:TP53::2kb_upstream_variant,processed_transcript::; ENST00000610292.4:TP53:P04637:5_prime_UTR_variant::c.-234A>T; ENST00000610538.4:TP53:P04637:5_prime_UTR_variant::c.-117A>T; ENST00000610623.4:TP53::2kb_upstream_variant::c.-1460A>T; ENST00000615910.4:TP53::missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000617185.4:TP53:P04637:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000618944.4:TP53::2kb_upstream_variant::c.-1460A>T; ENST00000619186.4:TP53::2kb_upstream_variant::c.-1460A>T; ENST00000619485.4:TP53:P04637:5_prime_UTR_variant::c.-117A>T; ENST00000620739.4:TP53:P04637:5_prime_UTR_variant::c.-117A>T; ENST00000622645.4:TP53:P04637:5_prime_UTR_variant::c.-117A>T; ENST00000635293.1:TP53::NMD_transcript_variant,5_prime_UTR_variant::c.-117A>T	7676594	0		TP53	Oncogene, TSG, fusion	somatic/germline	breast, colorectal, lung, sarcoma, adrenocortical, glioma, Spitzoid tumour, multiple other tumour types	breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types	TP53	chr17	7676594	T	A
9	chr12	25245384	T	A		Yes	KRAS	ENST00000256078.9	start_lost	2	c.1A>T	p.Met1?	ENST00000256078.9:KRAS:P01116:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000311936.8:KRAS:P01116:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000556131.1:KRAS::missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000557334.5:KRAS::missense_variant,start_lost:p.Met1?:c.1A>T	25245384	0		KRAS	Oncogene	somatic	pancreatic, colorectal, lung, thyroid, AML, other tumour types		KRAS	chr12	25245384	T	A
10	chr17	61861539	T	A		Yes	BRIP1	ENST00000259008.7	start_lost	2	c.1A>T	p.Met1?	ENST00000259008.7:BRIP1:Q9BX63:missense_variant,start_lost:p.Met1?:c.1A>T; ENST00000577598.5:BRIP1:Q9BX63:missense_variant,start_lost:p.Met1?:c.1A>T	61861539	0		BRIP1	TSG	germline		AML, leukaemia, breast	BRIP1	chr17	61861539	T	A
11	chr6	149683132	A	T		Yes	LATS1	ENST00000543571.6	missense_variant	4	c.1957T>A	p.Ser653Thr	ENST00000253339.9:LATS1:O95835:missense_variant:p.Ser653Thr:c.1957T>A; ENST00000392273.7:LATS1:O95835:missense_variant:p.Ser653Thr:c.1957T>A; ENST00000441107.5:LATS1::NMD_transcript_variant,3_prime_UTR_variant::c.*1644T>A; ENST00000542720.1:LATS1::2kb_downstream_variant,NMD_transcript_variant::c.*1644T>A; ENST00000542747.5:LATS1::processed_transcript::; ENST00000543571.6:LATS1:O95835:missense_variant:p.Ser653Thr:c.1957T>A	149683132	0		LATS1	TSG	somatic	skin basal cell carcinoma		LATS1	chr6	149683132	A	T
